1. A phase 2 study of E6011, an anti-Fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to biological disease-modifying antirheumatic drugs. Issue 4 (4th July 2021) Authors: Tanaka, Yoshiya; Takeuchi, Tsutomu; Yamanaka, Hisashi; Nanki, Toshihiro; Umehara, Hisanori; Yasuda, Nobuyuki; Tago, Fumitoshi; Kitahara, Yasumi; Kawakubo, Makoto; Torii, Kentaro; Hojo, Seiichiro; Kawano, Tetsu; Imai, Toshio Journal: Modern rheumatology Issue: Volume 31:Issue 4(2021) Page Start: 783 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and Safety of E6011, an Anti‐Fractalkine Monoclonal Antibody, in Patients With Active Rheumatoid Arthritis With Inadequate Response to Methotrexate: Results of a Randomized, Double‐Blind, Placebo‐Controlled Phase II Study. Issue 4 (18th February 2021) Authors: Tanaka, Yoshiya; Takeuchi, Tsutomu; Yamanaka, Hisashi; Nanki, Toshihiro; Umehara, Hisanori; Yasuda, Nobuyuki; Tago, Fumitoshi; Kitahara, Yasumi; Kawakubo, Makoto; Torii, Kentaro; Hojo, Seiichiro; Kawano, Tetsu; Imai, Toshio Journal: Arthritis & rheumatology Issue: Volume 73:Issue 4(2021) Page Start: 587 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP0223 EFFICACY AND SAFETY OF E6011, AN ANTI-FRACTALKINE MONOCLONAL ANTIBODY, IN MTX-IR PATIENTS WITH RHEUMATOID ARTHRITIS. (June 2019) Authors: Tanaka, Yoshiya; Takeuchi, Tsutomu; Yamanaka, Hisashi; Nanki, Toshihiro; Umehara, Hisanori; Yasuda, Nobuyuki; Tago, Fumitoshi; Kitahara, Yasumi; Kawakubo, Makoto; Torii, Kentaro; Hojo, Seiichiro; Kawano, Tetsu; Imai, Toshio Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗